Growth
TECHNOLOGIES
Innovative technologies are the key to the future. Join us on this path
Recombinant proteins/mABs
From discovery to pilot production: YURiA-PHARM performs full-cycle development of recombinant protein-based therapeutics.
Read more
RNA therapeutics
YURiA-PHARM is developing a technological platform for the production of next-generation gene therapies based on mRNA in situ amplification technology.
Read more
Biopolymer gels/Hyaluronic Acid
We produce safe and effective solutions for injectable implants based on hyaluronic acid and other biopolymers.
Read more
Nanoparticles for API delivery
The synthesis of polymer particles for the delivery of active pharmaceutical ingredients involves thorough optimization and control of their physical and chemical parameters.
Read more
Organic synthesis
We have experience in the development of methods for the synthesis and purification of API that comply with international quality standards.
Read more
Inhalations
Inhalation solutions and suspensions, dry powder inhalations and nasal sprays - we are developing inhalation products for targeted delivery and improved bioavailability of API.
Read more
Parenteral powders
We develop parenteral powders as an alternative to solutions to increase stability and shelf-life of complex and easily degradable active substances.
Read more
Parenteral solutions and emulsions
Solutions and emulsions for parenteral use have been our specialization over a long time. Quality of the API, the water used, and the packaging remain our main technological objectives.
Read more
